Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

23Andme Holding Co. (ME)

23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 184,435
  • Shares Outstanding, K 490,257
  • Annual Sales, $ 219,640 K
  • Annual Income, $ -666,700 K
  • 60-Month Beta 1.21
  • Price/Sales 0.87
  • Price/Cash Flow 2.64
  • Price/Book 1.02
Trade ME with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.67
  • Most Recent Earnings $-0.12 on 05/23/24
  • Next Earnings Date 08/13/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 138.31% ( -23.08%)
  • Historical Volatility 83.98%
  • IV Percentile 71%
  • IV Rank 50.37%
  • IV High 255.03% on 02/16/24
  • IV Low 19.85% on 01/16/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 800
  • Volume Avg (30-Day) 804
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 54,956
  • Open Int (30-Day) 54,460

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3653 +7.25%
on 07/02/24
0.5700 -31.26%
on 06/03/24
-0.1534 (-28.14%)
since 05/31/24
3-Month
0.3500 +11.94%
on 04/17/24
0.6380 -38.59%
on 05/15/24
-0.1372 (-25.94%)
since 04/02/24
52-Week
0.3500 +11.94%
on 04/17/24
2.0300 -80.70%
on 07/24/23
-1.3582 (-77.61%)
since 06/30/23

Most Recent Stories

More News
3 Ultra-High-Yield Dividend Stocks to Buy Hand Over Fist Right This Instant

Business development companies can be a lucrative source of passive income.

DOCU : 54.32 (-1.49%)
LYFT : 13.40 (-4.08%)
ME : 0.3918 (+4.15%)
HTGC : 20.89 (+1.56%)
HRZN : 12.09 (+0.67%)
ARCC : 20.88 (+0.82%)
Why 23andMe Stock Tumbled 10% on Tuesday

Is altruism a good idea for an unprofitable capitalistic enterprise?

ME : 0.3918 (+4.15%)
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next

Matterport is being acquired by a real estate giant, but it might not be the last ex-SPAC to go this route.

MTTR : 4.35 (-0.91%)
CSGP : 74.22 (+0.46%)
KIND : 2.60 (-1.89%)
ME : 0.3918 (+4.15%)
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

Several well-regarded funds run by famous billionaire investors bought shares of 23andMe during the last three months of 2023.

ME : 0.3918 (+4.15%)
GSK : 38.21 (-0.44%)
A Few Years From Now, You'll Probably Wish You'd Followed Billionaire Investors Into This Stock

Nu Holdings went from an idea to a $50 billion business over a handful of years. Several billionaire investors are betting on even more upside.

BRK.AX : 0.012 (-7.69%)
SQ : 64.58 (+1.16%)
SNOW : 141.92 (-0.60%)
META : 509.50 (+0.96%)
AAPL : 220.27 (+1.62%)
OKTA : 93.61 (-0.99%)
ZM : 58.34 (-1.47%)
ABNB : 154.34 (+1.79%)
DASH : 107.45 (-0.98%)
ME : 0.3918 (+4.15%)
CART : 33.17 (+2.38%)
NU : 12.35 (-0.08%)
Is 23andMe Stock a Smart Buy Right Now?

It's having trouble getting its core business model to work.

ME : 0.3918 (+4.15%)
The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them

Not all of my investments have been winners. Here are three that went badly and the important lessons I learned from them.

ME : 0.3918 (+4.15%)
LTCH : 0.3001 (unch)
AAPL : 220.27 (+1.62%)
TSLA : 231.26 (+10.20%)
IBM : 177.30 (+1.26%)
SHOP : 66.06 (+2.21%)
MELI : 1,596.48 (-0.07%)
T : 18.82 (-0.84%)
INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation Of 23andMe Holding Co (ME) Data Breach

New York, New York--(Newsfile Corp. - December 7, 2023) - 23andMe, a popular personal genomics and DNA analysis company run by 23andMe Holding Co. ("23 and Me") (NASDAQ: ME), recently suffered a massive...

ME : 0.3918 (+4.15%)
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch

USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
LLY : 906.71 (-0.84%)
RHHBY : 34.4300 (-0.61%)
BNTX : 78.76 (-0.09%)
ME : 0.3918 (+4.15%)
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END

LLY : 906.71 (-0.84%)
ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
RHHBY : 34.4300 (-0.61%)
BNTX : 78.76 (-0.09%)
ME : 0.3918 (+4.15%)

Business Summary

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition...

See More

Key Turning Points

3rd Resistance Point 0.4271
2nd Resistance Point 0.4095
1st Resistance Point 0.4006
Last Price 0.3918
1st Support Level 0.3741
2nd Support Level 0.3565
3rd Support Level 0.3476

See More

52-Week High 2.0300
Fibonacci 61.8% 1.3882
Fibonacci 50% 1.1900
Fibonacci 38.2% 0.9918
Last Price 0.3918
52-Week Low 0.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar